Clinical trial
Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma…
NCT00047177 · Pediatric Brain Tumor Consortium, Other · Completed
Key facts
| NCT number | NCT00047177 |
|---|---|
| Title | Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor |
| Official title | A Phase II Study of Oxaliplatin in Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumors and Atypical Teratoid Rhabdoid Tumors |
| Lead sponsor | Pediatric Brain Tumor Consortium, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug |
| Interventions | Oxaliplatin |
| Enrollment | 43 |
| Start date | Oct 1, 2002 |
| Primary completion | Aug 1, 2004 |
| Completion | Jul 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Oct 15, 2009 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: